CMS Won't Reconsider Medicare Coverage Limits for Alzheimer’s Treatment
- February 24, 2023
The Centers for Medicare & Medicaid Services (CMS) declined February 22 a request to reconsider a national coverage determination (NCD) issued last year that limited Medicare coverage of a new type of treatment for Alzheimer’s disease to only those patients who are enrolled in randomized controlled clinical trials.
ARTICLE TAGS
You must be logged in to access this content.